BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Human chorionic gonadotropin, Trichostatin A, rs3825942, PTEN, cell-cell adhesion)
Bookmark Forward

QuickView for B7 H1 (compound)


Genetic Markers

Most Correlated Genes

  1. ADM2
  2. CXCL8
  3. LINC-PINT
  4. EGR1
  5. ULBP1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
  2. KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
  3. MURARO_PANCREAS_DUCTAL_CELL
  4. KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP
  5. HALLMARK_TNFA_SIGNALING_VIA_NFKB
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. CD8+ T cells from OT-1 mice after exposure to PD-L1
  2. Colorectal cancer (HT29 & HCT116) and melanoma PES43 cells treated with Nivolumab, sPD-L1 or both
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Expression and Prognostic Significance of PD-L1 and NY-ESO1 in Gallbladder Carcinoma.
  2. The Role of Programmed Cell Death Ligand 1 Expression in Pituitary Tumours: Lessons from the Current…
  3. Evaluating regulatory consistency for international anti-PD-(L)1 clinical trials.
  4. Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transform…
  5. Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1-Time to Reassess the Evidence.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
  2. GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer Aft…
  3. Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced …
  4. PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
  5. Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.